Chemistry, pharmacology and cellular uptake mechanisms of thiometallate sulfide donors
Chemistry, pharmacology and cellular uptake mechanisms of thiometallate sulfide donors
BACKGROUND AND PURPOSE: A clinical need exists for targeted, safe and effective sulfide donors. We recently reported that ammonium tetrathiomolybdate (ATTM) belongs to a new class of sulfide-releasing drugs. Here, we investigate cellular uptake mechanisms of this drug class compared to sodium hydrosulfide (NaHS), and report on the thiometallate tungsten congener of ATTM, ammonium tetrathiotungstate (ATTT).
EXPERIMENTAL APPROACH: In vitro H2 S release was determined by head-space gas sampling of vials containing dissolved thiometallates. Thiometallate and NaHS bioactivity was assessed by spectrophotometry-derived sulfhaemoglobin formation. Cellular uptake dependence on the anion exchanger (AE)-1 was investigated in human red blood cells. ATTM/glutathione interactions were assessed by LC-MS/MS. Rodent pharmacokinetic and pharmacodynamic studies focussed on haemodynamics and inhibition of aerobic respiration.
KEY RESULTS: ATTM and ATTT both exhibit temperature-, pH-, and thiol-dependence of sulfide release. ATTM/glutathione interactions revealed the generation of inorganic and organic persulfides and polysulfides. ATTM showed greater ex vivo and in vivo bioactivity over ATTT, notwithstanding similar pharmacokinetic profiles. Cellular uptake mechanisms of the two drug classes are distinct; thiometallates show dependence on the AE-1 channel, while hydrosulfide itself was unaffected by inhibition of this pathway.
CONCLUSION AND IMPLICATIONS: Our demonstration that cellular uptake of thiometallates relies upon a plasma membrane ion channel advances our pharmacological knowledge of this drug class. It further supports their utility as cell-targeted sulfide donor therapies. Our results indicate that, as a more stable form, ATTT is better suited as a copper chelator. ATTM, a superior sulfide donor, may additionally participate in intracellular redox recycling.
Durham, Tom
b4a5b98f-dd23-466b-a2b0-55f8725232b4
Zander, David
91f242af-f76a-414e-b77b-334a1bf1e1f9
Stomeo, Niccolò
2e28b9a9-1cf1-4a41-9ab2-2e7a8d7a0116
Minnion, Magdalena
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Hogarth, Graeme
f802556c-a430-4fd3-84c4-942a695227cd
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Singer, Mervyn
87229716-c753-44ab-a382-3f93c1c5441d
Dyson, Alex
e288e219-cdac-4c63-85c6-9c2b6cdb194c
Durham, Tom
b4a5b98f-dd23-466b-a2b0-55f8725232b4
Zander, David
91f242af-f76a-414e-b77b-334a1bf1e1f9
Stomeo, Niccolò
2e28b9a9-1cf1-4a41-9ab2-2e7a8d7a0116
Minnion, Magdalena
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Hogarth, Graeme
f802556c-a430-4fd3-84c4-942a695227cd
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Singer, Mervyn
87229716-c753-44ab-a382-3f93c1c5441d
Dyson, Alex
e288e219-cdac-4c63-85c6-9c2b6cdb194c
Durham, Tom, Zander, David, Stomeo, Niccolò, Minnion, Magdalena, Hogarth, Graeme, Feelisch, Martin, Singer, Mervyn and Dyson, Alex
(2019)
Chemistry, pharmacology and cellular uptake mechanisms of thiometallate sulfide donors.
British Journal of Pharmacology.
(doi:10.1111/bph.14670).
Abstract
BACKGROUND AND PURPOSE: A clinical need exists for targeted, safe and effective sulfide donors. We recently reported that ammonium tetrathiomolybdate (ATTM) belongs to a new class of sulfide-releasing drugs. Here, we investigate cellular uptake mechanisms of this drug class compared to sodium hydrosulfide (NaHS), and report on the thiometallate tungsten congener of ATTM, ammonium tetrathiotungstate (ATTT).
EXPERIMENTAL APPROACH: In vitro H2 S release was determined by head-space gas sampling of vials containing dissolved thiometallates. Thiometallate and NaHS bioactivity was assessed by spectrophotometry-derived sulfhaemoglobin formation. Cellular uptake dependence on the anion exchanger (AE)-1 was investigated in human red blood cells. ATTM/glutathione interactions were assessed by LC-MS/MS. Rodent pharmacokinetic and pharmacodynamic studies focussed on haemodynamics and inhibition of aerobic respiration.
KEY RESULTS: ATTM and ATTT both exhibit temperature-, pH-, and thiol-dependence of sulfide release. ATTM/glutathione interactions revealed the generation of inorganic and organic persulfides and polysulfides. ATTM showed greater ex vivo and in vivo bioactivity over ATTT, notwithstanding similar pharmacokinetic profiles. Cellular uptake mechanisms of the two drug classes are distinct; thiometallates show dependence on the AE-1 channel, while hydrosulfide itself was unaffected by inhibition of this pathway.
CONCLUSION AND IMPLICATIONS: Our demonstration that cellular uptake of thiometallates relies upon a plasma membrane ion channel advances our pharmacological knowledge of this drug class. It further supports their utility as cell-targeted sulfide donor therapies. Our results indicate that, as a more stable form, ATTT is better suited as a copper chelator. ATTM, a superior sulfide donor, may additionally participate in intracellular redox recycling.
Text
Durham_et_al-2019-British_Journal_of_Pharmacology
- Accepted Manuscript
More information
Accepted/In Press date: 10 March 2019
e-pub ahead of print date: 29 March 2019
Identifiers
Local EPrints ID: 430265
URI: http://eprints.soton.ac.uk/id/eprint/430265
ISSN: 0007-1188
PURE UUID: 3c8c4764-3f8b-4b8b-bd02-7a712091ab43
Catalogue record
Date deposited: 23 Apr 2019 16:30
Last modified: 16 Mar 2024 07:44
Export record
Altmetrics
Contributors
Author:
Tom Durham
Author:
David Zander
Author:
Niccolò Stomeo
Author:
Magdalena Minnion
Author:
Graeme Hogarth
Author:
Mervyn Singer
Author:
Alex Dyson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics